30 related articles for article (PubMed ID: 1720884)
1. Peptide and protein assays using customizable bio-affinity arrays combined with ambient ionization mass spectrometry.
Zhang X; Wang W; Zare RN; Min Q
Chem Sci; 2021 Aug; 12(32):10810-10816. PubMed ID: 34476062
[TBL] [Abstract][Full Text] [Related]
2. Advances in biomarker research for pancreatic cancer.
Bhat K; Wang F; Ma Q; Li Q; Mallik S; Hsieh TC; Wu E
Curr Pharm Des; 2012; 18(17):2439-51. PubMed ID: 22372502
[TBL] [Abstract][Full Text] [Related]
3. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
4. Specificity of carcinoembryonic antigen, gastrointestinal cancer-associated antigen, tissue polypeptide antigen, fibrinopeptide A and gamma-glutamyltransferase in the diagnosis and follow-up of gastric cancer.
Abbasciano V; Levato F; Zavagli G
Oncology; 1988; 45(3):159-61. PubMed ID: 2897101
[TBL] [Abstract][Full Text] [Related]
5. Specificity of tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) for the diagnosis of hepatic metastases from large bowel cancers.
Abbasciano V; Levato F; Zavagli G
Med Oncol Tumor Pharmacother; 1989; 6(2):129-32. PubMed ID: 2473362
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
7. [CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay].
Abbasciano V; Graziano L; Arcudi D; Tassinari D; Nielsen I; Sartori S
Recenti Prog Med; 1991 Oct; 82(10):517-9. PubMed ID: 1684676
[TBL] [Abstract][Full Text] [Related]
8. Coagulation disorders and tumor markers in the diagnosis of pancreatic cancer.
Abbasciano V; Graziano L; Guerra S; Mazzotta D; Pollinzi V; Gilli G; Zavagli G
Oncology; 1991; 48(5):377-82. PubMed ID: 1720884
[TBL] [Abstract][Full Text] [Related]
9. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
[No Abstract] [Full Text] [Related]
10. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
Walenga JM; Fareed J; Hoppensteadt D
Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
[No Abstract] [Full Text] [Related]
11. [Clinical tests on the diagnosis of thrombosis].
Yamanaka M
Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
[No Abstract] [Full Text] [Related]
12. [Tumor markers. Current use in antineoplastic strategy].
Manguso L; Musset M; Coraggio F; Grimaldi G; Zito GA; Gattoni A; Catalano G; Astarita C; Papaleo G; Di Domenico M
Clin Ter; 1984 Aug; 110(3):231-41. PubMed ID: 6207976
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
